Jazz Pharma's decision to revoke U.S. patent for rival narcolepsy drug

Published Date: 02 Mar 2023

A U.S. court on Friday ordered Jazz Pharmaceuticals to revoke its patents related to its flagship narcolepsy drug Xyrem from the FDA-approved brand name drug after winning a case against Avadel foe CNS Pharmaceuticals.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Opposition to the Surgical Lymph Node Sampling Rule for Lung Resection.

2.

In cases of metastatic or recurrent head and neck cancer, gene-guided immunotherapy falls short.

3.

Remote monitoring can improve recovery from cancer surgery

4.

Knowing about and avoiding bladder cancer.

5.

PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot